Fresenius snaps up National Cardiovascular Partners

Candace Stuart | | Cardiovascular Business | Patient Care

The dialysis company Fresenius is acquiring National Cardiovascular Partners for an undisclosed amount.

National Cardiovascular Partners works with physicians to create independent outpatient cardiac catheterization and vascular laboratories. According to the company, physicians can retain a majority ownership in the lab.

Fresenius Medical Care specializes in dialysis products and services for treating patients with chronic kidney disease. It has more than 2,150 dialysis facilities in North America and 3,335 dialysis clinics worldwide.

The acquisition will be funded by cash and debt financing. Fresenius expects to generate more than $200 million in revenue in 2015 from the deal.

Candace Stuart, Contributor

Related Content

FDA and Boston Scientific issue urgent alert about pacemaker failures following 2 deaths
Concomitant ablation surgery during heart operations boosts long-term survival
Cardiologist explores why colchicine failed to help heart attack patients
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Most heart failure patients miss out on guideline-recommended palliative care
Cardiologist behind EARLY TAVR explains how proactive treatment improves patient outcomes

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.